Responsible for the development and effective implementation of biomarker and translational medicine strategies to support the clinical development of late-stage oncology assets.
Collaborate with the Clinical Biomarker Executive Director, to establish clear decision-making criteria, define patient segmentation strategies, and integrate these into clinical development plans.
Leverage cutting-edge technologies and methodologies to discover and clinically validate biomarkers, ensuring the biomarker strategy is fully aligned with the clinical plan.
Optimize decision-making in drug development and enable the identification of the right patient populations for medicines.
Collaborate closely with the Clinical Biomarker Executive Director to drive the design, alignment, and execution of clinical biomarker and translational medicine strategies focused on identifying predictive biomarkers that enable clinical success.
Validate and implement biomarker strategies, including target engagement, pharmacodynamic, and proof-of-mechanism biomarkers, for clinical-phase programs to support patient stratification, dose selection, and enable clinical go/no-go decisions.
Participate in tumor-specific Biomarker Matrix teams, with responsibility for executing clinical biomarker strategies for late-stage oncology programs, while working closely with internal and external stakeholders, as well as disease area strategy teams.
Represent Translational Medicine at Clinical Development Matrix Teams (CMT) to establish biomarker-driven decision-making criteria and their seamless integration into clinical study designs, aligning with clinical study objectives.
Identify cutting-edge science and technological advances to incorporate into biomarker strategies for guiding indication selection, patient enrichment, and combination strategies.
Oversee and/or develop sample testing plans and delivering high-quality biomarker data packages to inform clinical development and regulatory strategies.
Manage effective relationships with clinical and scientific operations, diagnostics, medical science, medical affairs, regulatory, portfolio management, and commercial functions.
Support the expansion of mechanism and disease understanding to generate insights for indication expansion and scientific exchange as needed.
Contribute to the company’s scientific credibility through publications and presentations.
Requirements
Minimum of 5 years of experience in the pharmaceutical industry, with a solid background in oncology clinical biomarkers -expertise in late-phase oncology studies- and translational research within clinical development.
Background as a Scientist and/or Physician.
Proven ability to lead cross-functional teams and execute strategic biomarker plans.
Experience conducting clinical trials and working as part of clinical study teams.
Expertise in interpreting clinical biomarker data and evaluating innovative biomarker technologies for clinical trial applications.
Strong interpersonal skills and ability to thrive in a team-oriented environment.
Demonstrated ability to influence teams and key leaders, with a track record of success.
Benefits
Comprehensive benefits program GSK offers US employees
Applicant Tracking System Keywords
Tip: use these terms in your resume and cover letter to boost ATS matches.